MAPK3 and depressive symptom measurement: Likewise, Wang et al. showed that ERK1/2 activity was significantly downregulated in the prefrontal cortex and hippocampus and that it was accompanied by enhanced MKP activity in patients with depression and in animal models of depression [35].